American Century Companies’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
SW
TCM
American Century Companies's NAGE Position: Q2 2026 in Review
American Century Companies sold out of Niagen Bioscience (NAGE) in Q2 2026, closing a stake of 74,490 shares — an estimated $329K sold.
American Century Companies first reported a position in NAGE in Q1 2025 and held it in 5 quarters. The position peaked at $1.38M in Q2 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.
- American Century Companies reported no remaining Niagen Bioscience position as of Q2 2026 after selling out during the quarter.
- American Century Companies sold 74,490 Niagen Bioscience shares in Q2 2026, an estimated $329K.
- American Century Companies first reported a position in Niagen Bioscience in Q1 2025 and held it in 5 quarters.
- American Century Companies's Niagen Bioscience position peaked at $1.38M in Q2 2025.
- 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.